Loading events...
Christina Schwarz will speak on the panel “Exploring New Litigation Concerns from Amneal and The FTC’s Latest Call for Orange Book Delistings” at ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA in NYC on October 14 – 15. The panel will examine how the recent Teva v. Amneal ruling will impact Orange Book patents and Hatch-Waxman litigation.
Tuesday, October 14, 2025 - Wednesday, October 15, 2025
New York, USA
Christina Schwarz will speak on the panel “Exploring New Litigation Concerns from Amneal and The FTC’s Latest Call for Orange Book Delistings” at ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA in NYC on October 14 – 15. The panel will examine how the recent Teva v. Amneal ruling will impact Orange Book patents and Hatch-Waxman litigation.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox